Gregory Demopulos
Chief Executive Officer at OMEROS CORPORATION
Net worth: 9 M $ as of 2024-02-28
Profile
Founder of Omeros Corp., Gregory A.
Demopulos presently is Chairman, President & Chief Executive Officer at this company.
Dr. Demopulos is also on the board of Onconome, Inc., Smead Funds Trust, Tessera, Inc. and Northwest NeuroNeighborhood.
He received an undergraduate degree from Stanford University and a doctorate from Stanford University School of Medicine.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
OMEROS CORPORATION
3.22% | 2023-12-30 | 2,026,986 ( 3.22% ) | 9 M $ | 2024-02-28 |
Gregory Demopulos active positions
Companies | Position | Start |
---|---|---|
OMEROS CORPORATION | Chief Executive Officer | 1994-06-15 |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Director/Board Member | - |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Director/Board Member | - |
Smead Funds Trust | Director/Board Member | - |
Northwest NeuroNeighborhood | Director/Board Member | - |
Training of Gregory Demopulos
Stanford University | Undergraduate Degree |
Stanford University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
OMEROS CORPORATION | Health Technology |
Private companies | 4 |
---|---|
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Health Technology |
Smead Funds Trust | Miscellaneous |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Electronic Technology |
Northwest NeuroNeighborhood |